# Cyclophosphamide

NDC: 10019-984
Generic name: Cyclophosphamide
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200807

FDA application: NDA012141

## Active ingredients

- CYCLOPHOSPHAMIDE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10019-984"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10019-984
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=769ded74-6186-40a8-8e44-ceff67287451